DEVELOPMENT AND EXPERIMENTAL JUSTIFICATION OF THE ANTIMICROBIAL ACTIVITY OF A GEL DOSAGE FORM BASED ON SALVIA OFFICINALIS EXTRACT

Authors

DOI:

https://doi.org/10.32782/health-2026.2.7

Keywords:

Salvia officinalis, antimicrobial activity, gel dosage form, phenolic compounds, minimum inhibitory concentration (MIC), carbomer, phytopharmaceutical, topical agents

Abstract

The rapid escalation of antibiotic resistance among pathogenic microorganisms necessitates the search for novel, effective, and safe antimicrobial agents. Herbal preparations containing naturally occurring bioactive compounds are of particular interest. Salvia officinalis L. is renowned for its high content of phenolic compounds, flavonoids, and essential oils, which possess significant antimicrobial and anti-inflammatory properties. The development of gel dosage forms incorporating plant extracts represents a promising frontier in modern pharmaceutical technology. The objective is to develop a gel dosage form based on the ethanolic extract of Salvia officinalis and to experimentally validate its antimicrobial activity against model microorganisms. The extract was obtained by maceration in 70% ethanol. Antimicrobial activity was evaluated using the agar well diffusion method against Staphylococcus aureus and Escherichia coli. The minimum inhibitory concentration (MIC) was determined using the twofold serial dilution method. The gel formulation was developed using a 1% carbomer base, incorporating the extract at concentrations of 2%, 5%, and 10%. Data were statistically analyzed using Student's t-test and ANOVA. The S. officinalis extract exhibited a dose-dependent antimicrobial response: inhibition zones for S. aureus ranged from 10.2±0.6 mm to 29.3±1.2 mm, and for E. coli from 8.5±0.5 mm to 25.4±1.1 mm. The MIC was determined to be 6.25 mg/mL for both test strains, Staphylococcus aureus and Escherichia coli, demonstrating the high antimicrobial efficacy of the extract even at relatively low concentrations. The gel formulation retained approximately 85–90% of the raw extract's potency. The Salvia officinalis extract demonstrated significant dose-dependent antimicrobial activity against Staphylococcus aureus and Escherichia coli. Incorporation of the extract into a carbomer gel maintained its antimicrobial efficacy, supporting the potential application of Salvia officinalis in the development of topical antimicrobial medicinal products.

References

Athanasiadis V., Lakka A., Palaiogiannis D., Pappas V. M., Bozinou E., Ntourtoglou G. Pulsed electric field and Salvia officinalis L. leaves: a successful combination for the extraction of high value-added compounds. Foods. 2021. № 10(9). Article 2014.

Soltanbeigi A., Yıldız M., Dıraman H., Terzi H., Sakartepe E., Yıldız E. Growth responses and essential oil profile of Salvia officinalis L. influenced by water deficit and various nutrient sources in the greenhouse. Saudi Journal of Biological Sciences. 2021. № 28(12). Р. 7327–7335.

Llurba Montesino N., Kaiser M., Mäser P., Schmidt T. J. Salvia officinalis L.: antitrypanosomal activity and active constituents against Trypanosoma brucei rhodesiense. Molecules. 2021. № 26(11). Article 3226.

Mohammadi-Cheraghabadi M., Modarres-Sanavy S. A. M., Sefidkon F., Rashidi-Monfared S., Mokhtassi-Bidgoli A. Improving water deficit tolerance of Salvia officinalis L. using putrescine. Scientific Reports. 2021. № 11. Article 21997.

Kačániová M., Vukovic N. L., Čmiková N., Galovičová L., Schwarzová M., Šimora V. Salvia sclarea essential oil chemical composition and biological activities. International Journal of Molecular Sciences. 2023. № 24(6). Article 5179.

European Committee on Antimicrobial Susceptibility Testing (EUCAST). Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. EUCAST Guidelines. 2022.

Demirpolat A. Essential oil composition analysis, antimicrobial activities, and biosystematic studies on six species of Salvia. Life. 2023. № 13(3). Article 634.

Maache S., Zbadi L., El Ghouizi A., Soulo N., Saghrouchni H., Siddique F. Antioxidant and antimicrobial effects of essential oils from two Salvia species with in vitro and in silico analysis targeting 1AJ6 and 1R4U proteins. Scientific Reports. 2023. № 13. Article 14038.

Державна фармакопея України. 2-ге вид. Доповнення 2. Харків : Державне підприємство «Український науковий фармакопейний центр якості лікарських засобів», 2018. 336 с. https://moz.gov.ua/uploads/0/4029-dn_20180314_476_dod.pdf

Woo S., Marquez L., Crandall W. J., Risener C. J., Quave C. L. Recent advances in the discovery of plant-derived antimicrobial natural products: insights from 2018–2022. Natural Product Reports. 2023. № 40. Р. 1271–1290.

Aćimović M., Pezo L., Čabarkapa I., Trudić A. Variation of Salvia officinalis essential oil and hydrolate composition and their antimicrobial activity. Processes. 2022. № 10(8). Article 1608.

Purgato G. A., Píccolo M. S., Scatamburlo Moreira M. A., Pizziolo V. R., Diaz-Muñoz G., Rossi C. C. Isolation and identification of antimicrobial multicyclic terpenoids from the medicinal plant Salvia officinalis and development of a formulation against clinical Staphylococcus aureus strains. Letters in Applied Microbiology. 2024. № 77(8). Article ovae077.

Bairamis A., Sotiropoulou N. S. D., Tsadila C., Tarantilis P., Mossialos D. Chemical composition and antimicrobial activity of essential oils and hydrosols from oregano, sage and pennyroyal against oral pathogens. Applied Sciences. 2024. № 14(8). Article 3238.

Nourozi E., Hedayati A., Mirjalili M. H., Madani H., Aliahmadi A., Zahedi A. A. First report on Salvia sahendica Boiss & Buhs roots biocomponents characterization by GC-MS and HPLC and antibacterial potency. Scientific Reports. 2024. № 14. Article 24916.

Farruggia D., Di Miceli G., Licata M., Leto C., Salamone F., Novak J. Foliar application of various biostimulants produces contrasting response on yield, essential oil and chemical properties of organically grown sage (Salvia officinalis L.). Frontiers in Plant Science. 2024. № 15. Article 1397489.

Jažo Z., Glumac M., Paštar V., Bektić S., Radan M., Carev I. Chemical composition and biological activity of Salvia officinalis L. essential oil. Plants. 2023. № 12(9). Article 1794.

Tayeb A. Y., Tateb A. Y., Tayeb A. Y. Antibacterial efficacy of Origanum majorana and Salvia officinalis extracts against Escherichia coli and Staphylococcus aureus. Scientific Journal of University of Benghazi. 2025. № 38(2).

Maded Z. K., Alsharif F. M., Alzahrani S. A., Alqahtani S. S., Alasmari A. F., Alharbi W. S. Development and optimization of dipyridamole– and roflumilast-loaded nanoemulsion and nanoemulgel. Pharmaceuticals. 2024. № 17(6). Article 803.

Zhao L., Chen J., Bai B., Song G., Zhang J., Yu H. et. al. Topical drug delivery strategies for enhancing drug effectiveness by skin barriers, drug delivery systems and individualized dosing. Frontiers in Pharmacology. 2024. № 14. Article 1333986.

Published

2026-11-13

Issue

Section

PHARMACY